Published in J Med Chem on October 01, 1975
Effect of apomorphine and its N-propyl homologue on ethanol withdrawal head twitches in mice. Br J Pharmacol (1977) 0.75
Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell (1995) 5.64
Vocal fold scarring: current concepts and management. Otolaryngol Head Neck Surg (1996) 1.77
Kappa opioid inhibition of morphine and cocaine self-administration in rats. Brain Res (1995) 1.49
Soil moisture redistribution as a mechanism of facilitation in savanna tree-shrub clusters. Oecologia (2005) 1.38
The effect of anaesthesia of the airway in dog and man: a study of respiratory reflexes, sensations and lung mechanics. Clin Sci Mol Med (1976) 1.36
Stereopsis and binocular vision after surgery for unilateral infantile cataract. J AAPOS (1999) 1.25
U50,488, a kappa opioid receptor agonist, attenuates cocaine-induced increases in extracellular dopamine in the nucleus accumbens of rats. Neurosci Lett (1994) 1.24
Antischistosomal drugs: past, present ... and future? Pharmacol Ther (1995) 1.20
Woody plant invasion of grasslands: establishment of honey mesquite (Prosopis glandulosa var.glandulosa) on sites differing in herbaceous biomass and grazing history. Oecologia (2013) 1.20
A new active metabolite of "Miracil D". Nature (1965) 1.15
Acetylsalicylic acid: inhibition of platelet aggregation in the rabbit. J Pharmacol Exp Ther (1971) 1.13
Cellular growth state differentially regulates enterocyte gene expression in butyrate-treated HT-29 cells. Cell Growth Differ (1996) 1.13
Pharmacology of some marijuana constituents and 2 heterocyclic analogues. Nature (1970) 1.11
Oxygen causes fetal pulmonary vasodilation through activation of a calcium-dependent potassium channel. Proc Natl Acad Sci U S A (1996) 1.11
Drugs derived from cannabinoids. 1. Nitrogen analogs, benzopyranopyridines and benzopyranopyrroles. J Med Chem (1976) 1.07
kappa opioid receptors in human microglia downregulate human immunodeficiency virus 1 expression. Proc Natl Acad Sci U S A (1996) 1.05
Purification of the opiate receptor from rat brain. Proc Natl Acad Sci U S A (1981) 1.04
Nitrocinnamoyl and chlorocinnamoyl derivatives of dihydrocodeinone: in vivo and in vitro characterization of mu-selective agonist and antagonist activity. J Pharmacol Exp Ther (1999) 1.04
Drug resistance in schistosomes. Parasitol Today (1993) 1.03
14 beta-[(p-nitrocinnamoyl)amino]morphinones, 14 beta-[(p-nitrocinnamoyl)amino]-7,8-dihydromorphinones, and their codeinone analogues: synthesis and receptor activity. J Med Chem (1993) 1.03
Sildenafil: from the bench to the bedside. CMAJ (2000) 1.02
Induction of physical dependence on morphine, codeine and meperidine in the rat by continuous infusion. J Pharmacol Exp Ther (1974) 1.01
Voltage-gated potassium channels in human ductus arteriosus. Lancet (2000) 1.00
The non specificity of specific nitric oxide synthase inhibitors. Biochem Biophys Res Commun (1992) 1.00
Schistosomicidal activity of lucanthone hydrochloride, hycanthone and their metabolites in mice and hamsters. J Parasitol (1967) 0.96
Hycanthone, a new active metabolite of lucanthone. J Med Chem (1967) 0.95
Molecular mechanics modeling of oligonucleotide adducts of the antitumor drug cis-diamminedichloroplatinum(II). Biopolymers (1987) 0.95
Studies of canine respiratory viruses. I. Experimental infection of dogs with an SV5-like canine parainfluenza agent. Am J Epidemiol (1971) 0.95
Ring-hydroxylated analogues of lucanthone as antitumor agents. J Med Chem (1982) 0.95
Metabolism of remifentanil during liver transplantation. Br J Anaesth (1998) 0.94
Calcium movements in resting and stimulated isolated rabbit atria. J Pharmacol Exp Ther (1967) 0.94
Induced hyperthermia in sedated humans and the concept of critical thermal maximum. Am J Physiol (1978) 0.93
Assignment of the appaloosa coat colour gene (LP) to equine chromosome 1. Anim Genet (2004) 0.92
The chemotherapy of schistosomiasis. Annu Rev Pharmacol Toxicol (1985) 0.92
A peripheral component of centrally acting muscle relaxants: chlormezanone and mephenesin. J Pharmacol Exp Ther (1967) 0.91
Thermographic evidence of reduced sympathetic tone with transcutaneous nerve stimulation. Anesthesiology (1979) 0.91
Naphthoquinone antimalarials. XXIX. 2-hydroxy-3-(omega-cyclohexylalkyl)-1,4-naphthoquinones. J Med Chem (1967) 0.91
Effects of anti-anaphylactic drugs upon passive cutaneous anaphylaxis mediated by graded doses of reaginic or non-reaginic antibodies in rats. Int Arch Allergy Appl Immunol (1974) 0.90
Redox control of oxygen sensing in the rabbit ductus arteriosus. J Physiol (2001) 0.89
Numerical solution of nonlinear pharmacokinetic equations: effects of plasma protein binding on drug distribution and elimination. J Pharm Sci (1971) 0.89
A comparison of oral and parenteral activity of hycanthone and lucanthone in experimental infections with Schistosoma mansoni. Am J Trop Med Hyg (1967) 0.89
Purification and characterization of the mu opiate receptor from rat brain using affinity chromatography. Proc Natl Acad Sci U S A (1985) 0.88
4-[(Aminoalkyl)amino]-1,2-dimethoxynaphthalenes as antimalarial agents. J Med Chem (1980) 0.86
Parasympatholytic (anticholinergic) esters of the isomeric 2-tropanols. 1. Glycolates. J Med Chem (1977) 0.85
Preventing morphine antinociceptive tolerance by irreversible mu opioid antagonists before the onset of their antagonism. J Pharmacol Exp Ther (1995) 0.85
Evidence for the mode of antischistosomal action of hycanthone. Life Sci (1985) 0.85
Daunomycin and adriamycin metabolism via reductive glycosidic cleavage. J Pharmacol Exp Ther (1972) 0.84
An analysis of multiple mechanisms of adenosine toxicity in baby hamster kidney cells. J Cell Physiol (1985) 0.84
Antiprotozoal quinones. I. Synthesis of 2-hydroxy-3-alkyl-1,4-naphthoquinones as potential coccidiostats. J Med Chem (1968) 0.84
Synthesis and characterization of 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene (BODIPY)-labeled fluorescent ligands for the mu opioid receptor. Biochem Pharmacol (1997) 0.84
Potential antiradiation drugs. 3. 2-amino-2-alkyl-1,3-propanedithiols and 3-amino-4-mercapto-1-butanol. J Med Chem (1966) 0.83
Torsional motion and elasticity of the deoxyribonucleic acid double helix and its nucleosomal complexes. Biochemistry (1982) 0.83
Hycanthone resistance in schistosomes correlates with the lack of an enzymatic activity which produces the covalent binding of hycanthone to parasite macromolecules. Mol Biochem Parasitol (1992) 0.83
The effect of calcium and sodium ion on the frequency-force relationship in cardiac muscle. J Pharmacol Exp Ther (1968) 0.83
Long-acting contraceptive agents: design of the WHO Chemical Synthesis Programme. Steroids (1983) 0.83
Whole body hyperthermia: a phase-I trial of a potential adjuvant to chemotherapy. Ann Intern Med (1979) 0.82
Craniofacial electromyogram activation response: another indicator of anesthetic depth. J Clin Monit Comput (1998) 0.81
Narcotic antagonists. Fortschr Arzneimittelforsch (1965) 0.81
Identification of kappa opioid receptors in the immune system by indirect immunofluorescence. Proc Natl Acad Sci U S A (1995) 0.81
Preparation and schistosomicidal activity of some 4-hydroxymethyl-3-chloroanilines. J Med Chem (1967) 0.81
Binding of oxamniquine to the DNA of schistosomes. Trans R Soc Trop Med Hyg (1990) 0.81
Pharmacokinetic consequences of plasma protein binding of drugs. Ann N Y Acad Sci (1973) 0.80
Effect of a ganglionic blocking agent on the orthostatic response in the rat. Arch Int Pharmacodyn Ther (1967) 0.78
The binding of salicylate to plasma protein from several animal species. J Pharm Pharmacol (1969) 0.78
Traumatic aneurysm of a common digital artery--a case report. J Hand Surg Am (1982) 0.78
Analysis of a SNP in exon 7 of equine OCA2 and its exclusion as a cause for appaloosa spotting. Anim Genet (2006) 0.78
Binding of tritiated hycanthone and hycanthone N-methylcarbamate to macromolecules of drug-sensitive and drug-resistant schistosomes. Mol Biochem Parasitol (1988) 0.78
Fluorescent staining of kappa opioid receptors using naltrexamine derivatives and phycoerythrin. J Immunol Methods (1997) 0.77
Lactic acidosis B associated with solid tumors. Minn Med (1986) 0.77
5 beta-Methyl-14 beta-(p-nitrocinnamoylamino)-7,8-dihydromorphinone and its corresponding N-cyclopropylmethyl analog, N-cyclopropylmethylnor-5 beta-methyl-14 beta-(p-nitrocinnamoylamino)- 7,8-dihydromorphinone: mu-selective irreversible opioid antagonists. J Pharmacol Exp Ther (1994) 0.77
14 beta-(2-bromoacetamido)morphine and 14 beta-(2-bromoacetamido)morphinone. J Med Chem (1983) 0.77
Recent progress in the chemotherapy of schistosomiasis. Prog Drug Res (1974) 0.77
14 beta-Chlorocinnamoylamino derivatives of metopon: long-term mu-opioid receptor antagonists. Eur J Pharmacol (1997) 0.77
Synthesis, rodent biodistribution, dosimetry, metabolism, and monkey images of carbon-11-labeled (+)-2 alpha-tropanyl benzilate: a central muscarinic receptor imaging agent. J Nucl Med (1992) 0.77
14 beta-(Bromoacetamido)morphine irreversibly labels mu opioid receptors in rat brain membranes. Biochemistry (1989) 0.76
Antinociceptive properties of two alkylating derivatives of morphinone: 14 beta-(thioglycolamido)-7,8-dihydromorphinone (TAMO) and 14 beta-(bromoacetamido)-7,8-dihydromorphinone (H2BAMO). J Pharmacol Exp Ther (1992) 0.76
Phase I and pharmacokinetic study of high volume intraperitoneal aclacinomycin-A (Aclarubicin). Invest New Drugs (1987) 0.76
Effects of the structurally novel opioid 14 alpha, 14' beta-[dithiobis [(2-oxo-2,1-ethanediyl)imino]]bis(7,8-dihydromorphinone) on schedule-controlled behavior and thermal nociception in rhesus monkeys. J Pharmacol Exp Ther (1996) 0.76
Emetic activity of reduced lysergamides. J Med Chem (1973) 0.76
Resistance of schistosomes to hycanthone and oxamniquine. Mem Inst Oswaldo Cruz (1989) 0.76
Historical perspective on the chemistry and development of naltrexone. NIDA Res Monogr (1981) 0.76
N-methylcarbamate derivatives of ellipticine and olivacine with cytotoxic activity against four human lung cancer cell lines. J Med Chem (1992) 0.76
Pharmacological study of 14 beta-(thioglycolamido)-7,8-dihydro-N(cyclopropylmethyl)-normor phinone (N-CPM-TAMO). J Pharmacol Exp Ther (1993) 0.76
An evaluation of liquid-crystal thermometry as a screening device for intraoperative hyperthermia. Anesth Analg (1979) 0.75
Identification and quantification of the indole alkaloid ibogaine in biological samples by gas chromatography-mass spectrometry. Biochem Pharmacol (1995) 0.75
Dual effects of aspirin in guinea-pig lungs. Br J Pharmacol (1976) 0.75
Napthoquinone antimalarials. XXX. 2-hydroxy-3-[omega-(1-adamantyl)alkyl]-1,4-naphthoquinones. J Med Chem (1967) 0.75
Design consideration for long-acting antagonists. Adv Biochem Psychopharmacol (1973) 0.75
Total synthesis of dl-19-nor-16,17-dehydroprogesterone. Proc Natl Acad Sci U S A (1969) 0.75
Recent developments in the chemotherapy of schistosomiasis. Prog Drug Res (1972) 0.75
Synthesis and schistosomicidal acitivity of 6-chloro-5-[2-(diethylamino)ethyl]amino-8-quinolinemethanol. J Med Chem (1970) 0.75
Similarity assessment and attribute scaling of sucrose and aspartame in grape drink. J Am Coll Nutr (1990) 0.75
5 beta-Methyl-14 beta-(p-nitrocinnamoylamino)-7,8-dihydromorphinone: a long-lasting mu-opioid receptor antagonist devoid of agonist properties. Eur J Pharmacol (1993) 0.75